Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-070257

Options or other derivatives

  • Director acquired 22,195 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Loy Spike Director 2026-06-17 Grant or award · Option to Buy +22,195 22,195 D: show line 1 in the form
Loading xslF345X06/ownership.xml…